-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Stoke Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2018 to 2023.
- Stoke Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$30M, a 10.2% decline year-over-year.
- Stoke Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$117M, a 4.4% decline year-over-year.
- Stoke Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$115M, a 9.98% decline from 2022.
- Stoke Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$104M, a 21.3% decline from 2021.
- Stoke Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$86.1M, a 62.3% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)